Search - tctmd.com

Displaying 81 - 100 of 1134

Sort: Relevancy | Date

Presentation TCT 2025

Predictions: How Will Trials Change Our Field?

Presenter: Jay S. Giri

October 27, 2025

Presentation TCT 2025

PE Interventions in 2030: What Do Future Devices Offer?

Presenter: Robert A. Lookstein

October 27, 2025

Presentation TCT 2025

Featured Clinical Research: Outcomes Among Patients with Massive PE after Computer Assisted Vacuum Thrombectomy: New Data from the STRIKE-PE Study

Presenter: Andrew Sharp

October 27, 2025

Presentation TCT 2025

Case Selection - Picking the Right Patients

Presenter: Felix Mahfoud

October 27, 2025

Presentation TCT 2025

The PERT Revolution: What am I Most Proud of?

Presenter: Kenneth Rosenfield

October 27, 2025

News Conference News TCT 2025

Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE

Caitlin E. Cox

October 26, 2025

Presentation TCT 2025

Building the Case for an All-Comers RCT in AR: Surgery vs. Transcatheter Replacement

Presenter: Vinod H. Thourani

October 26, 2025

Presentation TCT 2025

Contemporary Transcatheter Options for AR: Where Do We Stand?

Presenter: Torsten P. Vahl

October 26, 2025

Presentation TCT 2025

Surgical Repair of a Regurgitant Aortic Valve: When, How, and Why?

Presenter: Michael A. Borger

October 26, 2025

Presentation TCT 2025

How to Identify Clinically Relevant AR: The Role of Multimodality Imaging

Presenter: Omar K. Khalique

October 26, 2025

Presentation TCT 2025

Aortic Regurgitation in 2025: The Weight of the Problem (Diagnosis and Therapy)

Presenter: Robert O. Bonow

October 26, 2025

Presentation TCT 2025

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Presenter: Josep Rodés-Cabau

October 26, 2025

Presentation TCT 2025

Perspectives from TAVR UNLOAD

Presenter: Nicolas M. Van Mieghem

October 26, 2025

Presentation TCT 2025

Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients?

Presenter: Joao L. Cavalcante

October 26, 2025

Presentation TCT 2025

Not Much, We Need Stronger Evidence!

Presenter: Sanjay Kaul

October 26, 2025

Presentation TCT 2025

Yes, Most Definitely!

Presenter: Philippe Genereux

October 26, 2025

Presentation TCT 2025

Insights into the New European Guidelines

Presenter: Michael A. Borger

October 26, 2025

Presentation TCT 2025

Lessons Learned from 800+ Patients Treated with Tricuspid TEER: Update from the TRILUMINATE Pivotal Trial

Presenter: Jonathan G. Schwartz

October 26, 2025

Presentation TCT 2025

Evaluating Real-World Outcomes of the EVOQUE Valve in Early Commercial Experience from the STS/ACC TVT Registry

Presenter: Raj Makkar

October 26, 2025

Presentation TCT 2025

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

Presenter: Josep Rodés-Cabau

October 26, 2025

Advertisement

Predictions: How Will Trials Change Our Field?

PE Interventions in 2030: What Do Future Devices Offer?

Featured Clinical Research: Outcomes Among Patients with Massive PE after Computer Assisted Vacuum Thrombectomy: New Data from the STRIKE-PE Study

Case Selection - Picking the Right Patients

The PERT Revolution: What am I Most Proud of?

Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE

Building the Case for an All-Comers RCT in AR: Surgery vs. Transcatheter Replacement

Contemporary Transcatheter Options for AR: Where Do We Stand?

Surgical Repair of a Regurgitant Aortic Valve: When, How, and Why?

How to Identify Clinically Relevant AR: The Role of Multimodality Imaging

Aortic Regurgitation in 2025: The Weight of the Problem (Diagnosis and Therapy)

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Perspectives from TAVR UNLOAD

Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients?

Not Much, We Need Stronger Evidence!

Yes, Most Definitely!

Insights into the New European Guidelines

Lessons Learned from 800+ Patients Treated with Tricuspid TEER: Update from the TRILUMINATE Pivotal Trial

Evaluating Real-World Outcomes of the EVOQUE Valve in Early Commercial Experience from the STS/ACC TVT Registry

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content